Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.
Identifieur interne : 000349 ( PubMed/Corpus ); précédent : 000348; suivant : 000350Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.
Auteurs : S. Aidoo ; W K Ampofo ; J A Brandful ; S V Nuvor ; J K Ansah ; N. Nii-Trebi ; J S Barnor ; F. Apeagyei ; T. Sata ; D. Ofori-Adjei ; K. IshikawaSource :
- Journal of clinical microbiology [ 0095-1137 ] ; 2001.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : HIV Antibodies.
- geographic : Ghana.
- diagnosis : HIV Infections.
- immunology : HIV-1, HIV-2.
- methods : AIDS Serodiagnosis, Immunoblotting.
- virology : HIV Infections.
- Chromatography, Humans, Sensitivity and Specificity.
Abstract
In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.
DOI: 10.1128/JCM.39.7.2572-2575.2001
PubMed: 11427570
Links to Exploration step
pubmed:11427570Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.</title><author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S" last="Aidoo">S. Aidoo</name><affiliation><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W K" last="Ampofo">W K Ampofo</name></author><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name></author><author><name sortKey="Nuvor, S V" sort="Nuvor, S V" uniqKey="Nuvor S" first="S V" last="Nuvor">S V Nuvor</name></author><author><name sortKey="Ansah, J K" sort="Ansah, J K" uniqKey="Ansah J" first="J K" last="Ansah">J K Ansah</name></author><author><name sortKey="Nii Trebi, N" sort="Nii Trebi, N" uniqKey="Nii Trebi N" first="N" last="Nii-Trebi">N. Nii-Trebi</name></author><author><name sortKey="Barnor, J S" sort="Barnor, J S" uniqKey="Barnor J" first="J S" last="Barnor">J S Barnor</name></author><author><name sortKey="Apeagyei, F" sort="Apeagyei, F" uniqKey="Apeagyei F" first="F" last="Apeagyei">F. Apeagyei</name></author><author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T" last="Sata">T. Sata</name></author><author><name sortKey="Ofori Adjei, D" sort="Ofori Adjei, D" uniqKey="Ofori Adjei D" first="D" last="Ofori-Adjei">D. Ofori-Adjei</name></author><author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K" last="Ishikawa">K. Ishikawa</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11427570</idno><idno type="pmid">11427570</idno><idno type="doi">10.1128/JCM.39.7.2572-2575.2001</idno><idno type="wicri:Area/PubMed/Corpus">000349</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000349</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.</title><author><name sortKey="Aidoo, S" sort="Aidoo, S" uniqKey="Aidoo S" first="S" last="Aidoo">S. Aidoo</name><affiliation><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Ampofo, W K" sort="Ampofo, W K" uniqKey="Ampofo W" first="W K" last="Ampofo">W K Ampofo</name></author><author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name></author><author><name sortKey="Nuvor, S V" sort="Nuvor, S V" uniqKey="Nuvor S" first="S V" last="Nuvor">S V Nuvor</name></author><author><name sortKey="Ansah, J K" sort="Ansah, J K" uniqKey="Ansah J" first="J K" last="Ansah">J K Ansah</name></author><author><name sortKey="Nii Trebi, N" sort="Nii Trebi, N" uniqKey="Nii Trebi N" first="N" last="Nii-Trebi">N. Nii-Trebi</name></author><author><name sortKey="Barnor, J S" sort="Barnor, J S" uniqKey="Barnor J" first="J S" last="Barnor">J S Barnor</name></author><author><name sortKey="Apeagyei, F" sort="Apeagyei, F" uniqKey="Apeagyei F" first="F" last="Apeagyei">F. Apeagyei</name></author><author><name sortKey="Sata, T" sort="Sata, T" uniqKey="Sata T" first="T" last="Sata">T. Sata</name></author><author><name sortKey="Ofori Adjei, D" sort="Ofori Adjei, D" uniqKey="Ofori Adjei D" first="D" last="Ofori-Adjei">D. Ofori-Adjei</name></author><author><name sortKey="Ishikawa, K" sort="Ishikawa, K" uniqKey="Ishikawa K" first="K" last="Ishikawa">K. Ishikawa</name></author></analytic><series><title level="j">Journal of clinical microbiology</title><idno type="ISSN">0095-1137</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS Serodiagnosis (methods)</term><term>Chromatography</term><term>Ghana</term><term>HIV Antibodies (blood)</term><term>HIV Infections (diagnosis)</term><term>HIV Infections (virology)</term><term>HIV-1 (immunology)</term><term>HIV-2 (immunology)</term><term>Humans</term><term>Immunoblotting (methods)</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term><term>HIV-2</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>AIDS Serodiagnosis</term><term>Immunoblotting</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Chromatography</term><term>Humans</term><term>Sensitivity and Specificity</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11427570</PMID><DateCreated><Year>2001</Year><Month>06</Month><Day>27</Day></DateCreated><DateCompleted><Year>2001</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2014</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0095-1137</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>7</Issue><PubDate><Year>2001</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation></Journal><ArticleTitle>Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.</ArticleTitle><Pagination><MedlinePgn>2572-5</MedlinePgn></Pagination><Abstract><AbstractText>In West African countries such as Ghana, efficient human immunodeficiency virus (HIV) testing is a priority in the fight against AIDS. A new immunochromatographic rapid test, Determine HIV-1/2 (Abbott Diagnostics, North Chicago, Ill.), that detects antibodies against HIV type 1 (HIV-1) and/or HIV-2 was evaluated using Ghanaian blood samples. Two hundred four serum and/or plasma specimens were tested. HIV screening was done by a particle agglutination test and confirmed by a Western blot (WB) test as the "gold standard." The results revealed 125 HIV-seropositive AIDS patients, 75 HIV-seronegative healthy individuals, and 4 individuals for whom the HIV-1 result was indeterminate. The results obtained by the Determine HIV-1/2 assay and Diagnostic HIV SPOT (Genelabs), which is currently widely used in many districts in Ghana, were compared with those of the WB test, excluding the four HIV-1-indeterminate samples. The sensitivity of the Determine HIV-1/2 assay was 100%, compared with 98.0% for the HIV SPOT assay. The specificity was 100% for both tests. Determine HIV-1/2 is a single-step assay and was found to be rapid and easy to perform without any special equipment. It was highly sensitive and specific. The kit can be applied without electricity and water supplies, making it suitable for the detection of HIV antibodies especially in the rural areas of Ghana, West Africa.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aidoo</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampofo</LastName><ForeName>W K</ForeName><Initials>WK</Initials></Author><Author ValidYN="Y"><LastName>Brandful</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Nuvor</LastName><ForeName>S V</ForeName><Initials>SV</Initials></Author><Author ValidYN="Y"><LastName>Ansah</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Nii-Trebi</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Barnor</LastName><ForeName>J S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Apeagyei</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Sata</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ofori-Adjei</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 1987 Aug;25(8):1433-7</RefSource><PMID Version="1">3305558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1988 Feb 5;239(4840):610-6</RefSource><PMID Version="1">3340847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 1990 Sep 14;65(37):281-3</RefSource><PMID Version="1">2206928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1991 Feb 2;337(8736):286-7</RefSource><PMID Version="1">1671125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 1991 Oct;29(10):2280-4</RefSource><PMID Version="1">1939584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 1999 Feb;37(2):367-70</RefSource><PMID Version="1">9889220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 1993 Feb;6(2):115-9</RefSource><PMID Version="1">8433277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 1996 Nov 1;12(16):1575-8</RefSource><PMID Version="1">8911585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):815-9</RefSource><PMID Version="1">9643383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 1998 Oct 16;73(42):321-6</RefSource><PMID Version="1">9803168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 1998 Dec;36(12):3657-61</RefSource><PMID Version="1">9817891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 1992 May 15;67(20):145-9</RefSource><PMID Version="1">1599842</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015492" MajorTopicYN="N">AIDS Serodiagnosis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002845" MajorTopicYN="N">Chromatography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015498" MajorTopicYN="N">HIV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC88186</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>28</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>9</Month><Day>21</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>6</Month><Day>28</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11427570</ArticleId><ArticleId IdType="doi">10.1128/JCM.39.7.2572-2575.2001</ArticleId><ArticleId IdType="pmc">PMC88186</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000349 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000349 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:11427570
|texte= Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:11427570" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |